<DOC>
	<DOCNO>NCT02979483</DOCNO>
	<brief_summary>This study assess feasibility effect early integrative supportive care program patient Advanced pancreatic adenocarcinoma ( aPDAC ) .</brief_summary>
	<brief_title>Management Symptomatic Advanced Pancreatic Adenocarcinoma</brief_title>
	<detailed_description>Two-step cohort study : * Step 1 : A 14-day integrative supportive care program initiate early clinical suspicion aPDAC . According investigator 's assessment patient need , integrative supportive care program include : - management pain - nutritional support - pathologic diagnosis ( endoscopy guide percutaneous biopsy ascitis cytology ) - diagnostic compute image - endoscopic stenting bile duct and/or duodenum * Step 2 : Follow integrative supportive care program . According Eastern Cooperative Oncology Group Performance Status ( ECOG PS ) and/or chemotherapy - Group 1 : Patient become eligible treatment FOLFIRINOX nab-paclitaxel + gemcitabine / clinical trial - Group 2 : Patient end 14-day program ( Step 1 ) remain either : - Persisting ECOG PS ≥ 2 b - Clinico-biological feature make ineligible receive FOLFIRINOX nab-paclitaxel + gemcitabine regimens c - Patient ineligible therapeutic clinical trial</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>Inclusion Criteria STEP 1 : 1 . Pathologically confirm highly suspect aPDAC define pancreatic mass imaging , suspect distant metastasis , feature suggestive neuroendocrine tumor , and/or clinicobiological abnormality compatible diagnosis aPDAC , 2 . Age ≥ 18 year , 3 . Patients ECOG PS ≥ 2 clinicobiological feature preclude initial therapeutic clinical trial and/or treatment FOLFIRINOX gemcitabine + nabpaclitaxel , 4 . No prior history cancer , except : situ breast , cervix cancer , basal cell carcinoma and/or complete remission 3 year another cancer . 5 . Registration France French National Health Care System ( CMU include ) 6 . Patient able comply study protocol requirement view investigator , 7 . Before patient registration , write informed consent must obtain accord ICH/GCP national/local regulation , 8 . Patients require least two component integrative care program ( pain management , nutritional management , pathological assessment imaging , endoscopy/stent ) . Exclusion Criteria STEP 1 : 1 . Any medical , psychological , familial , sociological , geographical condition potentially hamper compliance study protocol followup schedule ; condition discuss patient registration trial , 2 . Patient protect law , 3 . Pregnant breast feeding woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>